In HP-Autonomy debacle, many advisers but little good advice

(Reuters) - When Hewlett Packard acquired Autonomy last year for $11.1 billion, some 15 different financial, legal and accounting firms were involved in the transaction -- and none raised a flag about what HP said Tuesday was a major accounting fraud.


HP stunned Wall Street with the allegations about its British software unit and took an $8.8 billion writedown, the latest in a string of reversals for the storied company.


HP Chief Executive Meg Whitman, who was a director at the company at the time of the deal, said the board had relied on accounting firm Deloitte for vetting Autonomy's financials and that KPMG was subsequently hired to audit Deloitte.


HP had many other advisers as well: boutique investment bank Perella Weinberg Partners to serve as its lead adviser, along with Barclays. Banking advisers on both sides of the deal were paid $68.8 million, according to data from Thomson Reuters/Freeman Consulting.


Barclays pocketed the biggest banker fee of the transaction at $18.1 million and Perella was paid $12 million. The company's legal advisers included Gibson, Dunn & Crutcher; Freshfields Bruckhaus Deringer; Drinker Biddle & Reath; and Skadden, Arps, Slate, Meagher & Flom, which advised the board.


On Autonomy's side of the table were Frank Quattrone's Qatalyst Partners, which specializes in tech deals and which picked up $11.6 million.


UBS, Goldman Sachs, Citigroup, JPMorgan Chase and Bank of America were also advising Autonomy and were paid $5.4 million each. Slaughter & May and Morgan Lewis served as the company's legal advisers.


While regulators in the United States and the United Kingdom, as well as the Federal Bureau of Investigation, are likely to spend many months if not years investigating what happened, legal experts said on Tuesday that it wasn't clear if any of the advisers would ultimately be held liable.


"The most logical deep pocket would be the acquired firm's auditors, who should have allegedly caught these defalcations," said James Cox, a professor at Duke University law school who specializes in corporate and securities law. Since both auditors missed the problems and it appeared to have taken HP a while to catch it after it took over Autonomy, the auditors may have a strong defense.


"You can have a perfectly sound audit and still have fraud exist," he said. A Deloitte UK spokesman said the company could not comment and would cooperate with any investigations.


The law firms and the bankers will likely argue that they were not hired to review the bookkeeping and had relied on the opinion of the auditors, securities law experts said.


Multiple sources with knowledge of the HP-Autonomy transaction added that the big-name banks on Autonomy's side were brought in days before the final agreement was struck. These sources said the banks were brought on as favors for their long relationships with the companies, in a little-scrutinized Wall Street practice of crediting -- and paying -- investment banks that actually have little do with the deal.


LAWSUITS, REPUTATIONS AT STAKE


Plaintiffs lawyers said they were taking calls from investors about HP on Tuesday. Darren Robbins, a San Diego-based plaintiff lawyer who represents shareholders, said the tech icon appears to have spent billions on a shoddy company without undertaking the proper due diligence, and thus misrepresented its finances to investors.


"I think they have serious troubles," he said.


But plaintiff lawyers may have difficulty bringing so-called derivative lawsuits against professional services firms, said Brian Quinn, an M&A professor at Boston College Law School. In those cases, plaintiff lawyers can sue third parties, such as auditors, on behalf of HP -- but they must convince a judge that HP's board is unfit to pursue those claims itself. In this situation, though, HP's board disclosed the alleged fraud itself, Quinn said.


Even if the bankers and lawyers escape any legal problems, they could suffer a reputational hit. The scrutiny could be particularly unwelcome for Perella Weinberg: the firm advised Japanese camera maker Olympus' acquisition of British Gyrus -- a transaction that prompted investigations in the United States, United Kingdom and Japan into fees and payments made by Olympus.


Olympus had hired Perella to execute the transaction, which included a fee paid to "advisers" of $687 million - way beyond the usual scale for a transaction valued at only $2 billion. Perella was not implicated in the matter.


Meanwhile, the most controversial banker involved in the HP-Autonomy deal, Frank Quattrone of Qatalyst, represented Autonomy and played a key role in getting HP to pay a high price.


A star investment banker in the 1990s, Quattrone had worked at Morgan Stanley, Deutsche Bank and Credit Suisse, and helped arrange some of the biggest tech initial public offerings of the era, including Amazon.com Inc and Cisco Systems Inc.


But his time at the top of Silicon Valley was curtailed by charges that he blocked an investigation into IPO kickbacks. After two trials failed to resolve his case, he ultimately reached a deal with prosecutors.


His return to the Silicon Valley M&A scene has impressed many in the tech world.


"His reputation is at an all-time high right now," said Dan Scheinman, the former head of mergers and acquisitions at Cisco who has worked with Quattrone on several deals.


Analysts almost uniformly deemed the $11.1 billion he got HP to pay for Autonomy as overly rich -- a compliment to him at the time, but possibly a hollow success if HP's allegations prove true.


(Reporting By Nadia Damouni and Nicola Leske in New York and Andrew Callus in London. Additional reporting by Dan Levine in San Francisco.; Editing by Peter Lauria, Jonathan Weber, Muralikumar Anantharaman, Janet McBride)


Read More..

Thunder edge Clippers 117-111 in overtime

OKLAHOMA CITY (AP) — Kendrick Perkins challenged his Oklahoma City Thunder teammates before a showdown of division leaders with the Los Angeles Clippers on Wednesday night.

The Thunder had lost their first two games this season against other top teams in the Western Conference, and Perkins wanted that trend to stop immediately.

It wasn't easy, but Oklahoma City got the job done.

Kevin Durant scored 35 points, Russell Westbrook added 23 and Oklahoma City's All-Star tandem scored all of the Thunder's points in overtime in a 117-111 victory over the Clippers.

"It felt good to finally get one of those wins, and we can move on now," Durant said.

Westbrook connected on a 3-pointer from the left wing to open the scoring in overtime, and Durant rattled one in from about the same spot two possessions later for a 108-104 advantage.

Westbrook then answered DeAndre Jordan's three-point play with a baseline jumper, and Oklahoma City was able to close it out from the foul line.

"This is a good win for us, especially against a team like that, that had some success lately," said Thabo Sefolosha, who hounded Clippers All-Star Chris Paul much of the game.

Blake Griffin led Los Angeles with 23 points and Jamal Crawford scored 20 for the Clippers, who had a six-game winning streak snapped after entering the game tied for the best record in the West.

After trailing for the previous 44 minutes, the Clippers finally pulled even at 102 when Matt Barnes drove for a layup with 36 seconds left in regulation. Griffin denied Durant the ball on the Thunder's ensuing possession, and Westbrook came up empty on a drive to the basket.

Paul then dribbled out the rest of the clock before missing a turnaround jumper from the left elbow as the horn sounded.

"I think the frustrating part is we had an opportunity to win and, regardless of what anybody says, it's going to be hard for us to win a game when I play that bad," said Paul, who missed 12 of 14 shots and ended up with nine points and nine assists.

"It's tough because you work so hard but there's going to be nights like that."

Los Angeles had been tied with Memphis for the West's best record at the start of the day but dropped behind Oklahoma City and San Antonio with the loss. The Clippers were trying to win at least seven games in a row for only the sixth time in franchise history, and the first time since 1991.

"We fought the whole game and Chris got a great look. We're going to live and die on that shot," Jordan said. "We fought but we definitely made some mistakes tonight. They made more plays than we did down the stretch."

Matt Barnes scored 19 points while replacing starting forward Caron Butler in the Clippers' lineup. Butler missed the game with a strained right shoulder sustained Monday night in a win at San Antonio.

Kevin Martin scored 20 points and Serge Ibaka chipped in 15 points and 12 rebounds for Oklahoma City before fouling out in overtime. Hasheem Thabeet also matched his career high with 10 points off the bench.

The Clippers won three out of four against Oklahoma City in a sometimes testy series last season that included Griffin's memorable throwdown over Perkins in a Clippers win and Perkins' retaliation with a hard foul to Griffin's face as Oklahoma City won the rematch.

Barnes had a couple scuffles with Ibaka and Perkins but nothing quite as noteworthy.

The Clippers ended up with a 54-38 edge scoring in the paint and a 28-10 advantage in second-chance points. Oklahoma City made up for it by making 34 of 39 free throws, while L.A. was 24 for 33.

Durant was 19 for 21 at the line, with coach Vinny Del Negro telling official Kevin Fehr after one call: "He doesn't need any help scoring."

"Those guys are physical and (I was) just trying to fight through it. Just trying to get there, man," Durant said. "I think early on, me driving and me getting into the paint, I was a little hesitant in the second half because I was turning the ball over.

"But I just tried to keep going. My teammates told me to just keep being aggressive, and that's what I tried to do."

The Thunder pushed ahead with a string of eight straight made baskets in the first quarter, and the lead stretched to 26-16 after Westbrook's extra effort turned a potential turnover into a three-point play for Thabeet.

The Clippers finally got back within striking distance early in the fourth, with Thunder coach Scott Brooks yelling to Durant to get off the bench with Los Angeles back within 78-75.

With Durant back in, Oklahoma City responded with the next six points to stabilize momentarily before the Clippers' final charge.

Notes: Los Angeles has held eight straight opponents below 46 percent shooting. The Thunder were just shy at 45.6 percent. ... Crawford made all four of his free throws, stretching his streak of consecutive makes to 29. He made 37 in a row in April. ... Jordan, one of the NBA's worst foul shooters at 42 percent, got Oklahoma City to stop hacking him intentionally in the fourth quarter by making three of four.

Read More..

Study finds mammograms lead to unneeded treatment

Mammograms have done surprisingly little to catch deadly breast cancers before they spread, a big U.S. study finds. At the same time, more than a million women have been treated for cancers that never would have threatened their lives, researchers estimate.

Up to one-third of breast cancers, or 50,000 to 70,000 cases a year, don't need treatment, the study suggests.

It's the most detailed look yet at overtreatment of breast cancer, and it adds fresh evidence that screening is not as helpful as many women believe. Mammograms are still worthwhile, because they do catch some deadly cancers and save lives, doctors stress. And some of them disagree with conclusions the new study reached.

But it spotlights a reality that is tough for many Americans to accept: Some abnormalities that doctors call "cancer" are not a health threat or truly malignant. There is no good way to tell which ones are, so many women wind up getting treatments like surgery and chemotherapy that they don't really need.

Men have heard a similar message about PSA tests to screen for slow-growing prostate cancer, but it's relatively new to the debate over breast cancer screening.

"We're coming to learn that some cancers — many cancers, depending on the organ — weren't destined to cause death," said Dr. Barnett Kramer, a National Cancer Institute screening expert. However, "once a woman is diagnosed, it's hard to say treatment is not necessary."

He had no role in the study, which was led by Dr. H. Gilbert Welch of Dartmouth Medical School and Dr. Archie Bleyer of St. Charles Health System and Oregon Health & Science University. Results are in Thursday's New England Journal of Medicine.

Breast cancer is the leading type of cancer and cause of cancer deaths in women worldwide. Nearly 1.4 million new cases are diagnosed each year. Other countries screen less aggressively than the U.S. does. In Britain, for example, mammograms are usually offered only every three years and a recent review there found similar signs of overtreatment.

The dogma has been that screening finds cancer early, when it's most curable. But screening is only worthwhile if it finds cancers destined to cause death, and if treating them early improves survival versus treating when or if they cause symptoms.

Mammograms also are an imperfect screening tool — they often give false alarms, spurring biopsies and other tests that ultimately show no cancer was present. The new study looks at a different risk: Overdiagnosis, or finding cancer that is present but does not need treatment.

Researchers used federal surveys on mammography and cancer registry statistics from 1976 through 2008 to track how many cancers were found early, while still confined to the breast, versus later, when they had spread to lymph nodes or more widely.

The scientists assumed that the actual amount of disease — how many true cases exist — did not change or grew only a little during those three decades. Yet they found a big difference in the number and stage of cases discovered over time, as mammograms came into wide use.

Mammograms more than doubled the number of early-stage cancers detected — from 112 to 234 cases per 100,000 women. But late-stage cancers dropped just 8 percent, from 102 to 94 cases per 100,000 women.

The imbalance suggests a lot of overdiagnosis from mammograms, which now account for 60 percent of cases that are found, Bleyer said. If screening were working, there should be one less patient diagnosed with late-stage cancer for every additional patient whose cancer was found at an earlier stage, he explained.

"Instead, we're diagnosing a lot of something else — not cancer" in that early stage, Bleyer said. "And the worst cancer is still going on, just like it always was."

Researchers also looked at death rates for breast cancer, which declined 28 percent during that time in women 40 and older — the group targeted for screening. Mortality dropped even more — 41 percent — in women under 40, who presumably were not getting mammograms.

"We are left to conclude, as others have, that the good news in breast cancer — decreasing mortality — must largely be the result of improved treatment, not screening," the authors write.

The study was paid for by the study authors' universities.

"This study is important because what it really highlights is that the biology of the cancer is what we need to understand" in order to know which ones to treat and how, said Dr. Julia A. Smith, director of breast cancer screening at NYU Langone Medical Center in New York. Doctors already are debating whether DCIS, a type of early tumor confined to a milk duct, should even be called cancer, she said.

Another expert, Dr. Linda Vahdat, director of the breast cancer research program at Weill Cornell Medical College in New York, said the study's leaders made many assumptions to reach a conclusion about overdiagnosis that "may or may not be correct."

"I don't think it will change how we view screening mammography," she said.

A government-appointed task force that gives screening advice calls for mammograms every other year starting at age 50 and stopping at 75. The American Cancer Society recommends them every year starting at age 40.

Dr. Len Lichtenfeld, the cancer society's deputy chief medical officer, said the study should not be taken as "a referendum on mammography," and noted that other high-quality studies have affirmed its value. Still, he said overdiagnosis is a problem, and it's not possible to tell an individual woman whether her cancer needs treated.

"Our technology has brought us to the place where we can find a lot of cancer. Our science has to bring us to the point where we can define what treatment people really need," he said.

___

Online:

Study: http://www.nejm.org/doi/full/10.1056/NEJMoa1206809

Screening advice: http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm

___

Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP

Read More..

Chevy Chase is leaving NBC's sitcom 'Community'

LOS ANGELES (AP) — The NBC series "Community" will finish the season without Chevy Chase.

Sony Pictures Television said Wednesday that the actor is leaving the sitcom by mutual agreement with producers.

His immediate departure means he won't be included in the last episode or two of the show's 13-episode season, which is still in production.

Chase had a rocky tenure playing a bored and wealthy man who enrolls in community college. The actor publicly expressed unhappiness at working on a sitcom and feuded last year with the show's creator and former executive producer, Dan Harmon.

The fourth-season premiere of "Community" is Feb. 7, when it makes a delayed return to the 8 p.m. EST Thursday time slot. The show's ensemble cast includes Joel McHale and Donald Glover.

Read More..

Judge to let Hostess liquidation proceed









Hostess Brands Inc. on Wednesday won permission from a U.S. bankruptcy judge to begin shutting down, and expressed optimism it will find new homes for many of its iconic brands, which include Twinkies, Drake's cakes and Wonder Bread.

U.S. Bankruptcy Judge Robert Drain in White Plains, New York authorized management, led by restructuring specialist Gregory Rayburn, to immediately begin efforts to wind down the 82-year-old company, a process expected to take one year.






"It appears clear to me that the debtors have taken the right course in seeking to implement the wind-down plan as promptly as possible," Drain said near the end of a four-hour hearing.

The judge authorized Hostess to begin the liquidation process one day after his last-ditch mediation effort between the Irving, Texas-based company and its striking bakers' union broke down.

Roughly 15,000 workers were expected to lose their jobs immediately, and most of the remaining 3,200 would be let go within four months.

"This is a tragedy, and we're well aware of it," Heather Lennox, a lawyer for Hostess, told the judge. "We are trying to be as sensitive as we can possibly be under the circumstances to the human cost of this."

Lennox said Hostess has received a "flood of inquiries" from potential buyers for several brands that could be sold at auction, and expects initial bidders within a few weeks.

Joshua Scherer, a partner at Perella Weinberg Partners, which is advising Hostess, said the company was in "active dialogue" over its Drake's brand with one "very interested" party that had toured a New Jersey plant on Tuesday.

He said that regional bakeries, national rivals, private equity firms and others have also expressed interest in various brands and that more than 50 nondisclosure agreements have been signed.

"These are iconic brands that people love," Scherer said.

While prospective buyers were not identified at the hearing, bankers have said rivals including Flowers Foods Inc. and Mexico's Grupo Bimbo SAB de CV were likely to be interested in some of the brands.

Representatives of neither company responded on Wednesday to requests for comment.

Scherer said Hostess could be worth $2.3 billion to $2.4 billion in a normal bankruptcy, an amount equal to its annual revenue. It also has about $900 million of secured debt and faces up to about $150 million of administrative claims.

Scherer expects a discount in this case because plants have already been closed and Hostess' value could fall further if the liquidation were dragged out.

"I've had buyers tell me, 'Josh, the longer it takes, the less value I'm going to be able to pay you,' " he said.

Hostess decided to liquidate on Nov. 16, saying it was losing about $1 million per day after the Bakery, Confectionery, Tobacco and Grain Millers Union, representing close to one-third of its workers, went on strike a week earlier.

The bakers union walked out after Drain authorized Hostess to impose pay and benefit cuts, which the International Brotherhood of Teamsters, Hostess' largest union, had accepted.

Hostess has about 33 plants, plus three it decided to close after the strike began, as well as 565 distribution centers and 570 bakery outlet stores.

Many of the 3,200 workers expected to stay on will help shut these properties and prepare them for sale. Hostess expects to need only about 200 employees by late March.

Rayburn, a former chief restructuring officer for the bankrupt phone company WorldCom Inc., said that letting 15,000 workers go now helps preserve their ability to obtain unemployment benefits.

"I need to maximize the value of the estate, but I need to do the best I can for my employees," he said.

Hostess filed for Chapter 11 protection on Jan. 11, its second bankruptcy filing in less than three years.

The case is In re: Hostess Brands Inc. et al, U.S. Bankruptcy Court, Southern District of New York, No. 12-22052.

Read More..

Bartender wounded in hotel stabbing: 'It was bone-chilling'









Bradford Burner didn't stop to think when he heard a blood-curdling scream and saw a man race through the Westin Hotel and into the streets of the Magnificent Mile still crowded from the Festival of Lights. He gave chase.


"The way the person screamed, 'Stop that person!' — it was bone-chilling," said Burner, 35, who was bartending Saturday night at the Westin's Grill on the Alley restaurant. "I just reacted."


Speaking out Tuesday for the first time, Burner said the man displayed a knife as he closed in on him near some shops at the Hancock building.





"Someone yelled something. The gentleman turned around (and) saw me coming toward him," Burner told Chicago Tribune columnist John Kass on WLS-AM 890. "The next thing I know, he was lunging at me with a sharp object."


Burner was cut on the left side of his chest and fell to the sidewalk.


"I was like, 'What the hell just happened?'" Burner told the Tribune after his radio interview.


Police and prosecutors said Jimmy Harris had tried to rob an Oak Brook doctor, Mir Jafar Shah, in the restaurant bathroom and stabbed and struck him during a scuffle before fleeing. Harris, 56, a parolee with 60 arrests who had just been freed from prison eight days earlier, is being held without bond on charges of attempted murder, aggravated battery and unlawful restraint.


In the radio interview, Burner said that after he had been cut on the chest, the assailant ran across the street before slowing down, trying to blend in among the families strolling along North Michigan Avenue.


"I looked right over at him. He paused for two seconds and looked directly back at me, and then he proceeded down the steps," Burner said. "His demeanor was that of a person trying to get away ... sacrifice everything to get away from the situation."


Burner recalled that parents and their small children stared down at him as he lay bleeding. He decided not to wait for an ambulance and hailed a cab. He hopped in and asked the driver, "What was the fastest he could get me to Northwestern (Memorial) Hospital?"


"The taxi driver was freaked out," Burner said. "He was like, 'Are you crazy?' I said, I'm really serious about this,'" said Burner, showing the cabbie his bloodied shirt and vest.


Burner said he tipped the driver — how much, he can't remember — before going inside to be stitched up for the deep wound.


Burner bristled at being called a hero.


"My heart goes out to (Shah) and their whole family that they had to go through this tragedy," Burner said. "I was just trying to stop an individual that was doing something wrong."


Tribune reporter Jason Meisner contributed.


wlee@tribune.com


Twitter: @MidnoirCowboy





Read More..

Microsoft vs. Google trial over patents finishes up

SEATTLE (Reuters) - A Google expert witness testified on Tuesday that Microsoft will make roughly $94 billion in revenue through 2017 from its Xbox game console and Surface tablet that use Google's patented wireless technology.


Michael Dansky, an expert for Google's Motorola Mobility unit, testified on the last day of a high stakes trial over patents between Microsoft and Google in Seattle. The $94 billion figure he cited also includes a wireless adapter that Microsoft no longer sells. It was not clear how far back he was counting past revenues.


Microsoft declined comment on the figure.


The week-long trial in a Seattle federal court examined how much of a royalty Microsoft Corp should pay Google Inc for a license to some of Motorola's patents. Google bought Motorola earlier this year for $12.5 billion, partly for its library of communications patents.


Motorola had sought up to $4 billion a year for its wireless and video patents, while Microsoft argues its rival deserves just over $1 million a year.


If U.S. District Judge James Robart decides Google deserves only a small royalty, then its Motorola patents would be a weaker bargaining chip for Google to negotiate licensing deals with rivals.


The rapid rise of smartphones has sparked an explosion of litigation between major players disputing ownership of the underlying technology and the design of handsets.


Apple Inc and Microsoft have been litigating in courts around the world against Google and partners like Samsung Electronics Co Ltd, which use the Android operating system on their mobile devices.


Apple contends that Android is basically a copy of its iOS smartphone software, and Microsoft holds patents that it contends cover a number of Android features.


In return, Motorola and some other Android hardware makers launched countering legal action.


Before trial, Robart said testimony about patent license agreements between Microsoft, Motorola and other tech companies could be disclosed to the public, along with other sensitive financial information.


However, the judge reversed himself this week and said he was bound by appellate precedent to keep that information secret. On Tuesday he cleared the courtroom and heard two hours of testimony in secret.


During the open session, Dansky said Motorola's video patents are crucial to Microsoft and other tech companies, and deserve a high royalty.


"You will have a difficult time selling smart phones or tablets," Dansky said, without Motorola's technology.


Robart is not expected to release a ruling for several weeks as both companies must file further legal briefs.


The case in U.S. District Court, Western District of Washington is Microsoft Corp. vs. Motorola Inc., 10-cv-1823.


(Reporting by Lisa Dembiczak; Writing by Dan Levine; Editing by Richard Pullin)


Read More..

Jack Taylor scores 138 points for Grinnell

After a poor shooting weekend, Grinnell guard Jack Taylor was given the green light to shoot his way out of a slump.

It only took 108 shots for Taylor to make a mockery of the college basketball record books.

Taylor scored 138 points to shatter the NCAA scoring record in Division III Grinnell's 179-104 victory over Faith Baptist Bible on Tuesday night in Grinnell, Iowa.

Taylor, a 5-foot-10, 170-pound sophomore from Black River Falls, Wis., made 27 of 71 3-point attempts, was 52 of 108 overall from the field and added seven free throws on 10 attempts in 36 minutes.

"It felt like anything I tossed up was going in," Taylor told The Associated Press.

Rio Grande's Bevo Francis held the NCAA scoring record with 113 points against Hillsdale in 1954. In 1953, Francis had 116 against Ashland Junior College. Frank Selvy is the only other player to reach triple figures, scoring 100 points for Division I Furman against Newberry in 1954. The previous Grinnell record was 89 by Griffin Lentsch last Nov. 19 against Principia.

Under coach David Arseneault, the Pioneers press and shoot 3s like nobody else in the country in any level. They've led the nation in scoring for 17 of the past 19 seasons while ranking first nationally in 3-point shooting for the 15 of those past 19 years. But none of them have had a night quite like Taylor — who never saw this coming.

Taylor recently transferred to Grinnell, located about 50 miles east of Des Moines, after playing one season for Wisconsin-La Crosse. He struggled in his debut at the nearby Wartburg Tournament over the weekend by hitting only 11 of 41 shots — including only 6 of 34 3-point attempts Still, he averaged 23.5 points a game.

But Taylor started Tuesday's night game off slow — at least according to his standards. His coaches figured the best way to get him on track was for him to keep chucking, so that's what Taylor did.

"Maybe my cold shooting from the weekend was affecting me," Taylor said. "But then they started to drop."

Taylor had 58 points at halftime.

Then he got hot.

Taylor was 32 of 58 shooting — including 18 3s — in the final 20 minutes and averaged an astounding four points a minute in the second half.

"I don't think reality has set in yet," Taylor said.

Faith Baptist's David Larson also had a big game, scoring 70 points on 34-of-44 shooting.

Carmelo Anthony and the New York Knicks were amazed by Taylor's feat when they heard about it after their victory in New Orleans.

"I never heard of nothing like that. That's like a video game," Anthony said, an incredulous look on his face. "How can you shoot 100 times, though?"

He joked that from now on when someone asks if he's taking too many shots, he'll mention "that someone shot it 108 times."

Raymond Felton also was astounded by the 108 shots.

"His elbow has got to be sore," Felton said.

___

AP Sports Writer Brett Martel in New Orleans contributed to this report.

___

Follow Luke Meredith on Twitter: http://www.twitter.com/LukeMeredithAP

Read More..

“Hitchcock” trains lens on the love story of Alfred and Alma
















NEW YORK (Reuters) – She won Oscar gold for her uncanny performance as Britain’s Queen Elizabeth, but Helen Mirren‘s latest portrayal finds her as the power behind the throne — or, more precisely, the director’s chair.


In “Hitchcock,” Mirren stars opposite Anthony Hopkins as legendary director Alfred Hitchcock’s devoted wife Alma Reville, and early buzz has her a contender for another Oscar nomination.













The film, which opens in limited release on Friday, explores the domestic life of one of Hollywood‘s most iconic and revered directors, set during the days of his struggle to put the ground-breaking 1960 classic, “Psycho” on the silver screen.


Toggling back and forth between his on-set battles with censors and his cast including Janet Leigh (Scarlett Johansson), Vera Miles (Jessica Biel) and Tony Perkins (James D’Arcy), and his strained relationship with Alma as she copes with his well-documented obsession with his ravishing leading ladies, “Hitchcock” treats film fans to a glimpse of bygone Hollywood.


But it paints a more nuanced and sympathetic portrait of the director Hopkins called “a damaged man” than the recent television film “The Girl,” which dramatized the hell Hitchcock put Tippi Hedren through during filming of “The Birds.”


“It’s a great role,” Mirren said of Alma, a film editor and assistant director in her own right who ceded the spotlight to her husband, but as the film makes clear was involved in virtually every aspect of his films and even re-cut “Psycho” into the masterpiece it is known as today.


“So, you don’t turn that down,” she told Reuters.


Having won her Oscar as one of the world’s most famous women, Mirren said she finds herself drawn to “the ones I don’t know anything about, like Alma. Those are the most fun.”


With little to go on, Mirren said she turned to the 2003 book “Alma Hitchcock: The Woman Behind the Man,” by the couple’s daughter Patricia, who also acted in several Hitchcock films.


“I’m not that much of a film buff that I knew about Alma, and I had no idea about Hitchcock‘s private life,” she said, adding the book aimed “to bring her mother out of the shadows.”


HITCH THE BRAND


By all accounts making the movie about the movies was a joy, with Mirren and Hopkins co-starring in their first film together under first-time director Sacha Gervasi (“Anvil: The Story of Anvil”), who fixed a script that had made the rounds.


Hopkins described it as the “most fun” since his Oscar-winning role in the thriller “Silence of the Lambs.”


Mirren recalled rushing off to work each day: “I couldn’t wait.” And it helped that the actors have the same approach.


“There’s no mystery to it … They talk about chemistry, and Helen agrees with me, there’s no such thing. You know your part, she knows hers, and off you go, hope it works,” Hopkins said.


But Mirren and Hopkins, who is also being touted for an Oscar nomination, parted ways when speculating on how the auteur director, who never won an Oscar during five decades of work, would have fared in the Hollywood of today.


“He would have despaired,” Hopkins said. “It would have been anathema to him. That kind of artistry is gone.”


Corporate control means “you have eight or nine producers on the set, everyone’s got a say in the scripts, and even craft services!”


But Mirren differed, imagining “he’d do brilliantly well.”


“He was a great salesman, and the Hollywood of today is so much about being a salesman and being able to sell yourself as a brand,” she explained. “He did that brilliantly. I think the two of them sold Hitch. Hitch was the faceman, he was the brand.”


“Also,” she added, “his filmmaking techniques would be incredibly successful,” given the technological advances since Hitchcock’s death in 1980.


Hitchcock was on a roll in his early 60s, with his “Psycho” follow-up, the shocking thriller “The Birds” becoming a hit and a much-loved classic. But none of the handful of films he made afterward attained their iconic status.


Mirren, 67, by contrast, truly hit her stride during her 40s, despite a steady two-decade career by that point.


Starting with the TV show “Prime Suspect” to the films “Gosford Park,” “The Queen” and “The Last Station,” she racked up four Oscar nominations and a mantel full of Emmys, which raises a question about the validity of complaints that Hollywood has no use for actresses over 40.


“I think what has changed is, the world around has changed,” Mirren said when reflecting on her success and acclaim.


“I was lucky that I hit my 40s just as the world around me was changing. Twenty years before I never would have been cast in ‘Prime Suspect’ because there were no women inspectors.”


And so, she looks forward.


“As I’ve carried on, my God, 20 years ago it was inconceivable that you’d have a female president of the United States,” she said.


“Now, the next president of America may well be a woman, and if there is a female president, that means that if a movie comes along, and there’s the president of America …” She laughs.


“You know what I mean?”


(Editing by Christine Kearney)


Movies News Headlines – Yahoo! News



Read More..

OB/GYNs back over-the-counter birth control pills

WASHINGTON (AP) — No prescription or doctor's exam needed: The nation's largest group of obstetricians and gynecologists says birth control pills should be sold over the counter, like condoms.

Tuesday's surprise opinion from these gatekeepers of contraception could boost longtime efforts by women's advocates to make the pill more accessible.

But no one expects the pill to be sold without a prescription any time soon: A company would have to seek government permission first, and it's not clear if any are considering it. Plus there are big questions about what such a move would mean for many women's wallets if it were no longer covered by insurance.

Still, momentum may be building.

Already, anyone 17 or older doesn't need to see a doctor before buying the morning-after pill — a higher-dose version of regular birth control that can prevent pregnancy if taken shortly after unprotected sex. Earlier this year, the Food and Drug Administration held a meeting to gather ideas about how to sell regular oral contraceptives without a prescription, too.

Now the influential American College of Obstetricians and Gynecologists is declaring it's safe to sell the pill that way.

Wait, why would doctors who make money from women's yearly visits for a birth-control prescription advocate giving that up?

Half of the nation's pregnancies every year are unintended, a rate that hasn't changed in 20 years — and easier access to birth control pills could help, said Dr. Kavita Nanda, an OB/GYN who co-authored the opinion for the doctors group.

"It's unfortunate that in this country where we have all these contraceptive methods available, unintended pregnancy is still a major public health problem," said Nanda, a scientist with the North Carolina nonprofit FHI 360, formerly known as Family Health International.

Many women have trouble affording a doctor's visit, or getting an appointment in time when their pills are running low — which can lead to skipped doses, Nanda added.

If the pill didn't require a prescription, women could "pick it up in the middle of the night if they run out," she said. "It removes those types of barriers."

Tuesday, the FDA said it was willing to meet with any company interested in making the pill nonprescription, to discuss what if any studies would be needed.

Then there's the price question. The Obama administration's new health care law requires FDA-approved contraceptives to be available without copays for women enrolled in most workplace health plans.

If the pill were sold without a prescription, it wouldn't be covered under that provision, just as condoms aren't, said Health and Human Services spokesman Tait Sye.

ACOG's opinion, published in the journal Obstetrics & Gynecology, says any move toward making the pill nonprescription should address that cost issue. Not all women are eligible for the free birth control provision, it noted, citing a recent survey that found young women and the uninsured pay an average of $16 per month's supply.

The doctors group made clear that:

—Birth control pills are very safe. Blood clots, the main serious side effect, happen very rarely, and are a bigger threat during pregnancy and right after giving birth.

—Women can easily tell if they have risk factors, such as smoking or having a previous clot, and should avoid the pill.

—Other over-the-counter drugs are sold despite rare but serious side effects, such as stomach bleeding from aspirin and liver damage from acetaminophen.

—And there's no need for a Pap smear or pelvic exam before using birth control pills. But women should be told to continue getting check-ups as needed, or if they'd like to discuss other forms of birth control such as implantable contraceptives that do require a physician's involvement.

The group didn't address teen use of contraception. Despite protests from reproductive health specialists, current U.S. policy requires girls younger than 17 to produce a prescription for the morning-after pill, meaning pharmacists must check customers' ages. Presumably regular birth control pills would be treated the same way.

Prescription-only oral contraceptives have long been the rule in the U.S., Canada, Western Europe, Australia and a few other places, but many countries don't require a prescription.

Switching isn't a new idea. In Washington state a few years ago, a pilot project concluded that pharmacists successfully supplied women with a variety of hormonal contraceptives, including birth control pills, without a doctor's involvement. The question was how to pay for it.

Some pharmacies in parts of London have a similar project under way, and a recent report from that country's health officials concluded the program is working well enough that it should be expanded.

And in El Paso, Texas, researchers studied 500 women who regularly crossed the border into Mexico to buy birth control pills, where some U.S. brands sell over the counter for a few dollars a pack. Over nine months, the women who bought in Mexico stuck with their contraception better than another 500 women who received the pill from public clinics in El Paso, possibly because the clinic users had to wait for appointments, said Dr. Dan Grossman of the University of California, San Francisco, and the nonprofit research group Ibis Reproductive Health.

"Being able to easily get the pill when you need it makes a difference," he said.

___

Online:

OB/GYN group: http://www.acog.org

Read More..